Select Page
Who we are

About RDT


Rapid Dose Therapeutics, RDT, is a Canadian life sciences company which provides disruptive proprietary drug delivery technologies designed to improve patient outcomes.

Formed because of a recognized need to move drug delivery to a new level. RDT provides product innovation, production, and consultation to the pharmaceutical and healthcare manufacturing industry.

RDT’s Mission

“To create novel, convenient, enhanced rapid delivery therapeutics to improve healthcare outcomes for patients.”

Board of Directors


Mark Upsdell

Director and Chief Executive Officer

Mr. Upsdell has over 25 years of experience in management, sales and strategic planning. Mr. Upsdell is the Founder and has been a director and the CEO of RDT since its incorporation on May 3rd, 2017. Prior to that, Mr. Upsdell was Director, Global Strategy and Planning of Cisco Systems, Inc. (a high-tech conglomerate) from 2011 to April 2017. Mr. Upsdell was also formerly a sales executive for Hewlett- Packard (a technology company) from January 2000 to November 2011. Mr. Upsdell graduated from Conestoga College in 1982 with a diploma in Business Administration and graduated in 1983 from McMaster University with a M.Sc. in Computer Science.

Peter Thilo Hasler

Mr. Hasler has been an equity analyst for more than 25 years. He is the founder and analyst of Sphene Capital GmbH, which offers high-quality equity and bond research to selected companies. In 2015, he founded Sphaia advisory GmbH, which offers corporate finance and communications services to small- and medium-sized companies. He is a member of the board and lecturer of the DVFA and lecturer with several Munich universities on company valuation and financing as well as company valuation. He is the author of numerous essays and books on company valuation, corporate finance, capital investment and investor relations and regularly publishes columns in the financial media.

John McKimm

Mr. McKimm is currently the Chief Executive Officer of Smart Employee Benefits Inc. (formerly TSXV: SEB) and his experience spans over 35 years of serving as a director and an officer of many public and private companies, where he provided operations, investment banking, and corporate finance expertise. This experience covers a range of sectors, including financial services, healthcare, insurance, computer hardware, software and services, manufacturing, petrochemical, mining, oil and gas, food processing, telecom, waste management, biotechnology, and retail. He has personally identified, negotiated and executed more than 150 individual merger, acquisition and financing transactions, both as a principal and as an agent. Mr. McKimm possesses a deep knowledge in dealing with emerging and growth companies, specifically with respect to providing specialty services in government funding programs, strategic and financial restructurings, mergers and acquisitions, operational and financial restructuring and the arrangement of financings. Mr. McKimm’s experience is global.

Mr. McKimm is a graduate of the University of New Brunswick with a Bachelor of Business Administration, and a graduate of the University of Western Ontario with a Masters of Business Administration and a Bachelor of Laws. Mr. McKimm also has a number of investment industry certifications and designations. He has published on select investment and financial restructuring topics.

Marisa Cornacchia, RN, COHNC, DOHS, MBA, CRM

Marisa is a Registered Nurse with over two decades of experience in both Critical Care and Occupational Health nursing. Marisa also holds an MBA with a concentration in Project Management, and a Certification in Risk Management from The University of Toronto.

Marisa has worked with several national employers in both private and public sectors to manage projects and develop health care strategies including rehabilitation and mental health programs for several organizations.  Marisa has experience with clinic management and program design having lead a successful growth strategy for a national leader in primary care and chronic pain clinics.  With two decades of nursing experience combined with an MBA, Marisa provides both clinical and academic health care knowledge. Marisa has experience working with medical professionals and allied health care professionals to develop national programs with multi-disciplinary practices to manage acute care, chronic care, and mental health care.

In her previous role as VP Clinical Operations Marisa was responsible for the overall program implementation of the Health and Wellness division including the overall delivery of program services, clinical and administrative staff, as well as financial and KPI reporting.

As a staff RN at the Hospital for Sick Children for the past 28 years, Marisa maintains a dedicated role as a leader in the care of children and their families, and has developed the skill to manage unpredictable challenges, identify priorities, and develop action plans provide emergency/critical care. Marisa is the recipient of the Robert Saulter Humanitarian Award for the Hospital.  The completion of a Masters of Business Administration has provided the learning tools for which to better understand organizational design, structure change management, measure business effectiveness, and project manage IT solutions.

Marisa currently affiliated with the Canadian Institute for Patient Safety, and The American Society for Healthcare Risk Management and sits on the Board of Directors for the Canadian Institute for the Relief of Pain and Disability.

Andrew Duckman
Proposed Director

Mr. Duckman has 20 years of experience as a trusted corporate development and investment advisor with an entrepreneurial spirit.  Mr. Duckman is currently a partner at Fort Capital Partners and owner and CEO of AJD Financial Group Inc.  Prior to that, Mr. Duckman was Managing Director at Echelon Wealth Partners from 2022 to 2023 and Managing Director at Bloom Burton & Co. from 2014 to 2022.  Mr. Duckman founded his first company while in high school and over the years his companies have invented, sourced and distributed products with national retailers, telecoms and financial services companies that have generated millions of dollars in revenue. Mr. Duckman has worked from the ground up and developed top-tier family office relationships with some of the most influential investors and companies across the country. Mr. Duckman’s experience spans several sectors including healthcare, real estate, digital photography, technology and financial services.

Christine Hrudka
Proposed Director

 Ms. Hrudka is a Canadian pharmacist, entrepreneur, leader, public speaker, and advocate for women in business. She owned chain and independent pharmacies, served as Chair of the Canadian Pharmacy Association, and has led the advancement of many critical topics provincially, nationally, and internationally. She is a board member of Pharmacy Association of Saskatchewan, the North American representative of the World Pharmacy Council, and an Ad-hoc member of the Minister Anand COVID-19 Supply Council. She is a director of Avricore Health Inc. (TSXV: AVCR) and previously also served as Director of Pharmapod, Director and committee member of Governance and Compensation, Smart Employee Benefits, Board chair of Aither Ingredient Corporation and Member-at-Large, University of Saskatchewan Senate. She has volunteered for many community boards such as SREDA, YWCA, United Way, and WESK. Christine holds a B.Sc. in Pharmacy (BSP) and a designation from the Institute of Corporate Directors, Designation (ICD.D).





Team Members


DOSE Leadership Team
Mark Upsdell – Founder & CEO
Jason Lewis – SVP Business Development
Doug Hyland – CFO CPA, CA

Consultants & Advisors
Dr. Shammit Kapur, Dentist
Radwan Almofti, PHD Pharmaceutical Sciences

Board Of Directors
Mark Upsdell- Founder & CEO
John McKimm (Independent)
Peter Thilo Hasler (Independent)
Christine Hrudka (Independent)
Andrew Duckman (Independent)
Marisa Cornacchia (Independent)

Medical Advisory Board
Dr. Rick Tytus BSc.Phm, MD, CCFP, FCFP                                                                                    
Dr. James Meschino, DC, MS, ROHP
Dr. Michael Glogauer, Head of Dental Oncology, UHN,
Princess Margaret Cancer Centre, Dental Oncology and Maxillofacial Prosthetics

Chief Scientist – Ben Macphail, MSc
Marketing & Communications – Nissrine Ghannoum
Operations – Paula MacBeth







Stay connected